If You Are Living With HIV
If you are living with HIV, you may be eligible to participate in one of our clinical trials. Please click the links below if you would like more information about our open trials. If you are interested in participating, please contact Don Garmon at 212-327-7290 or e-mail him at dgarmon@adarc.org.Clinical Trials for Patients Living with HIV
(MMA-0613)
A study of the safety, tolerability and pharmacokinetics of experimental drug KD-247
A study of the safety, tolerability and pharmacokinetics of experimental drug KD-247
The reason for doing this research is to determine the safety and tolerability of 3 infusions (the introduction of fluid into a vein) over 2 weeks of the experimental study drug KD-247 in HIV-1 seropositive (infected) individuals.
(MMA-0591)
HIV Elite Controller Study
HIV Elite Controller Study
The focus of the studies to be conducted under this protocol and consent form is on the detailed analysis of host cellular and humoral immune responses, comprehensive human genome analysis and genomic analysis of the infecting viruses isolated from persons that control HIV Infection.
(MMA 0666) An Inter-disciplinary Approach to HIV and Other Infectious Diseases of Drug Users
The reason for doing this research is to determine whether injecting drugs can make HIV infection worse - that is cause activation of the immune system which increases the destruction of the immune system.
One way to measure HIV disease is by looking at the gut, or gastrointestinal tract. The body produces many types of immune cells in the gut, including T-cells that are the primary target of HIV. It is thought that injecting drugs may activate the immune system which in turn may increase destruction of immune cells in the gut. To test this theory, we are obtaining biopsies from the lower intestines of HIV + injection drug users, HIV+ people who do not inject drugs and people who do not use drugs and are HIV-.
One way to measure HIV disease is by looking at the gut, or gastrointestinal tract. The body produces many types of immune cells in the gut, including T-cells that are the primary target of HIV. It is thought that injecting drugs may activate the immune system which in turn may increase destruction of immune cells in the gut. To test this theory, we are obtaining biopsies from the lower intestines of HIV + injection drug users, HIV+ people who do not inject drugs and people who do not use drugs and are HIV-.